View study details on clinicaltrials.gov.
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Studyof Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD